Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.88
Delayed Data
As of Nov 27
 +0.55 / +2.58%
Today’s Change
13.12
Today|||52-Week Range
25.82
-7.76%
Year-to-Date

Today’s Trading

Previous close21.33
Today’s open21.39
Day’s range21.35 - 21.88
Volume7,211
Average volume (3 months)477,023
Market cap$1.2B
Data as of 12:58pm ET, 11/27/2020

Growth & Valuation

Earnings growth (last year)+1.04%
Earnings growth (this year)+15.83%
Earnings growth (next 5 years)-22.60%
Revenue growth (last year)-3.95%
P/E ratio9.1
Price/Sales3.25
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp+0.18+0.72%
KPTIKaryopharm Therapeut...+0.37+2.51%
ZGNXZogenix Inc+0.50+2.37%
INVAInnoviva Inc+0.26+2.46%
Data as of 12:59pm ET, 11/27/2020

Financials

Next reporting dateMarch 2, 2021
EPS forecast (this quarter)$0.53
Annual revenue (last year)$392.8M
Annual profit (last year)$113.1M
Net profit margin28.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts